| Symbol | AUTR |
|---|---|
| Name | AUTRIS |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 07096 Panama Balboa Office Center Avenida Balboa y Calle 27 |
| Telephone | +1 7864001888 |
| Fax | — |
| — | |
| Website | http://www.autrisgroup.com/ |
| Incorporation | US |
| Incorporated On | 2008 |
| Employees | — |
| Fiscal Year | 6/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Cardoze Accountants; |
| Audit Status | UNAUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0001441362 |
| Description | FREEDOM AND SUSTAINABILITY ORIENTED COMMUNITY CREATOR Autris is the holding company for EcoVillages, the developer of the Veritas Villages freedom and sustainability-oriented communities throughout Latin America, and Vida Verde, an agroforestry development company. Autris is breaking ground with Veritas Villages by creating a new concept in community living based on its own F.I.R.S.T. philosophy (Freedom, Independence, Resilience, Sustainability and Transparency). Political divisiveness and authoritarian leaning governments are gripping the western world, and an ever-expanding group of informed people are looking to break free from it. Autris provides the solution by creating Veritas Village freedom and sustainability-oriented communities throughout Latin America. Vida Verde Agroforestry provides the opportunity to not only own lucrative producing land in our teak and avocado agroforestry projects, but also to use the ownership of these parcels to apply for a second residency and ultimately citizenship in various countries in Latin America. Many people looking for a freedom and sustainability-oriented lifestyle are also wanting to have multiple residencies. The combination of a Veritas Village community home and residency through the investment in the home or through Vida Verde Agroforestry parcels gives our clients both a landing pad and residency and is a powerful solution that makes Autris a whole new asset class with high expansion potential. Additional info from OTC: |
No news found.